RRC ID 44297
Author Sogawa N, Hirai K, Sogawa C, Ohyama K, Miyazaki I, Tsukamoto G, Asanuma M, Sasaki A, Kitayama S.
Title Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
Journal Life Sci
Abstract AIMS:Cisplatin (CDDP) is a potent anticancer agent, but severe renal toxicity can limit its use. We investigated the protective effect of cepharanthin (CE), a biscoclaurin alkaloid, on the renal toxicity of CDDP.
MAIN METHODS:Mice were given CDDP along with CE. Effects of CE on CDDP toxicity were investigated by assaying markers of renal toxicity together with MT expression, and by histopathological examination of the kidney. MT-null mice were also examined.
KEY FINDINGS:CE induced expression of metallothionein (MT). Pre-administration of CE attenuated an increase in blood urea nitrogen (BUN) concentrations after the CDDP injection. A histochemical analysis demonstrated protection against CDDP-induced necrocytosis of kidney tissues by CE. The protective effect of CE did not occur in the MT-null mice.
SIGNIFICANCE:Pretreatment with CE may reduce the renal toxicity of CDDP through expression of MT.
Volume 92(12)
Pages 727-32
Published 2013-4-9
DOI 10.1016/j.lfs.2013.01.031
PII S0024-3205(13)00072-6
PMID 23399700
MeSH Animals Antineoplastic Agents / toxicity* Antineoplastic Agents, Phytogenic / therapeutic use* Benzylisoquinolines / therapeutic use* COS Cells Cell Line Chlorocebus aethiops Cisplatin / toxicity* Kidney / drug effects Kidney / metabolism Kidney / pathology Kidney Diseases / chemically induced* Kidney Diseases / genetics Kidney Diseases / prevention & control* Male Metallothionein / genetics* Mice Mice, Inbred C57BL RNA, Messenger / genetics Up-Regulation / drug effects
IF 3.647
Times Cited 9
WOS Category MEDICINE, RESEARCH & EXPERIMENTAL PHARMACOLOGY & PHARMACY
Resource
Human and Animal Cells COS-7(RCB0539) MDCK(RCB0995)